DE69916640D1 - Im magen verweilendes arzneimittel mit verzögerter wirkstoffabgabe - Google Patents
Im magen verweilendes arzneimittel mit verzögerter wirkstoffabgabeInfo
- Publication number
- DE69916640D1 DE69916640D1 DE69916640T DE69916640T DE69916640D1 DE 69916640 D1 DE69916640 D1 DE 69916640D1 DE 69916640 T DE69916640 T DE 69916640T DE 69916640 T DE69916640 T DE 69916640T DE 69916640 D1 DE69916640 D1 DE 69916640D1
- Authority
- DE
- Germany
- Prior art keywords
- immunological
- active ingredients
- medicinal product
- delayed active
- layers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9812977A FR2784583B1 (fr) | 1998-10-16 | 1998-10-16 | Composition pharmaceutique a residence gastrique et a liberation controlee |
FR9812977 | 1998-10-16 | ||
PCT/FR1999/002443 WO2000023045A1 (fr) | 1998-10-16 | 1999-10-12 | Composition pharmaceutique a residence gastrique et a liberation controlee |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69916640D1 true DE69916640D1 (de) | 2004-05-27 |
DE69916640T2 DE69916640T2 (de) | 2005-03-31 |
Family
ID=9531635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69916640T Expired - Lifetime DE69916640T2 (de) | 1998-10-16 | 1999-10-12 | Im magen verweilendes arzneimittel mit verzögerter wirkstoffabgabe |
Country Status (12)
Country | Link |
---|---|
US (1) | US6861072B1 (de) |
EP (1) | EP1121099B1 (de) |
JP (1) | JP2002527464A (de) |
AT (1) | ATE264666T1 (de) |
AU (1) | AU774723B2 (de) |
CA (1) | CA2347105C (de) |
DE (1) | DE69916640T2 (de) |
DK (1) | DK1121099T3 (de) |
ES (1) | ES2219062T3 (de) |
FR (1) | FR2784583B1 (de) |
PT (1) | PT1121099E (de) |
WO (1) | WO2000023045A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9407386D0 (en) | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
US7250176B1 (en) * | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
KR100685945B1 (ko) | 2000-12-29 | 2007-02-23 | 엘지.필립스 엘시디 주식회사 | 액정표시장치 및 그 제조방법 |
FR2820318B1 (fr) * | 2001-02-08 | 2005-12-23 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu |
FR2820319B3 (fr) * | 2001-02-08 | 2003-12-05 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu |
EP1411901B1 (de) | 2001-07-04 | 2010-08-18 | Sun Pharma Advanced Research Company Ltd | Magenretentionssystem mit kontrollierter arzneimittelfreisetzung |
CA2409552A1 (en) | 2001-10-25 | 2003-04-25 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
US20050013863A1 (en) | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
JP2005132803A (ja) * | 2003-10-31 | 2005-05-26 | Ono Pharmaceut Co Ltd | 胃内滞留固形剤 |
ES2247897B1 (es) * | 2003-12-18 | 2007-05-01 | Gat Formulation Gmbh | Tabletas con matriz polimerica emulsionada para emision controlada de gases y procedimiento para su fabricacion. |
TW200533391A (en) | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
FR2874325B1 (fr) * | 2004-08-19 | 2006-10-20 | Sanofi Synthelabo | Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine |
US20070092565A1 (en) * | 2005-10-25 | 2007-04-26 | Pharmascience Inc. | Gastric retention drug delivery system |
EP1957052A2 (de) * | 2005-10-25 | 2008-08-20 | Pharmascience Inc. | System zur abgabe eines magenretentionsmittels |
US7674396B2 (en) * | 2005-11-08 | 2010-03-09 | Plensat Llc | Method and system for treatment of eating disorders |
US7879355B2 (en) * | 2005-11-08 | 2011-02-01 | Plensat Llc | Method and system for treatment of eating disorders |
US20110112383A1 (en) * | 2005-11-08 | 2011-05-12 | Plensat, Inc | Devices, systems and methods for treatment of eating disorders |
WO2007080509A2 (en) * | 2006-01-12 | 2007-07-19 | Wockhardt Ltd | Sustained release compositions of alfuzosin |
HUE040311T2 (hu) | 2006-04-04 | 2019-02-28 | Kg Acquisition Llc | Vérlemezke aggregációt gátló szert és sav inhibitort tartalmazó orális dózisformák |
TW200815045A (en) * | 2006-06-29 | 2008-04-01 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of ropinirole and methods of use thereof |
WO2008102235A1 (en) * | 2007-02-20 | 2008-08-28 | Aurobindo Pharma Limited | Controlled release formulations of alfuzosin |
AT505225A1 (de) | 2007-04-26 | 2008-11-15 | Sanochemia Pharmazeutika Ag | 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen |
DE102007026037A1 (de) * | 2007-06-04 | 2008-12-11 | Lts Lohmann Therapie-Systeme Ag | Gastroretentives System mit Alginat-Körper |
WO2009084040A1 (en) * | 2007-12-28 | 2009-07-09 | Rubicon Research Private Limited | Once a day formulation of angiotensin receptor blockers |
JP2012500230A (ja) | 2008-08-18 | 2012-01-05 | 北京天衡▲薬▼物研究院 | 胃内滞留薬物放出システム及びその製造方法と使用 |
US20100249423A1 (en) * | 2009-03-09 | 2010-09-30 | Sanochemia Pharmazeutika Ag | Tolperisone controlled release tablet |
KR101137466B1 (ko) * | 2009-06-12 | 2012-04-20 | 안국약품 주식회사 | 염산 알푸조신 함유 서방성 정제 |
FR2949061B1 (fr) * | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | Microgranules flottants |
FR2967352B1 (fr) * | 2010-11-12 | 2012-12-28 | Unither Dev | Comprime effervescent pour l'administration par voie orale de principes actifs |
CN102475690B (zh) * | 2010-11-30 | 2016-06-01 | 安国药品株式会社 | 内含盐酸阿夫唑嗪的缓释片剂 |
WO2019113079A1 (en) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
KR20200110317A (ko) | 2017-12-05 | 2020-09-23 | 선오비온 파마슈티컬스 인코포레이티드 | 결정형 및 이의 제조 방법 |
SG11202113266YA (en) | 2019-06-04 | 2021-12-30 | Sunovion Pharmaceuticals Inc | Modified release formulations and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
DE69613966T2 (de) * | 1995-03-17 | 2002-04-04 | The Boots Co., Plc | Pharmazeutische zusammensetzungen mit pektin |
WO1997047285A1 (en) * | 1996-06-10 | 1997-12-18 | Depomed, Inc. | Gastric-retentive oral controlled drug delivery system with enhanced retention properties |
NZ334018A (en) * | 1996-08-29 | 1999-06-29 | Synthelabo | Multilayered controlled release tablet comprising a layer of alfuzosin hydrochloride and at least one layer of hydrophillic polymers |
US5972389A (en) * | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
FR2762213B1 (fr) * | 1997-04-18 | 1999-05-14 | Synthelabo | Composition pharmaceutique a retention gastrique |
PT1003476E (pt) * | 1997-08-11 | 2005-05-31 | Alza Corp | Forma de dosagem de agente activo de libertacao prolongada adaptada para retencao gastrica |
-
1998
- 1998-10-16 FR FR9812977A patent/FR2784583B1/fr not_active Expired - Fee Related
-
1999
- 1999-10-12 JP JP2000576822A patent/JP2002527464A/ja active Pending
- 1999-10-12 ES ES99947537T patent/ES2219062T3/es not_active Expired - Lifetime
- 1999-10-12 DK DK99947537T patent/DK1121099T3/da active
- 1999-10-12 US US09/807,573 patent/US6861072B1/en not_active Expired - Lifetime
- 1999-10-12 AU AU60947/99A patent/AU774723B2/en not_active Ceased
- 1999-10-12 DE DE69916640T patent/DE69916640T2/de not_active Expired - Lifetime
- 1999-10-12 PT PT99947537T patent/PT1121099E/pt unknown
- 1999-10-12 AT AT99947537T patent/ATE264666T1/de active
- 1999-10-12 WO PCT/FR1999/002443 patent/WO2000023045A1/fr active IP Right Grant
- 1999-10-12 CA CA002347105A patent/CA2347105C/en not_active Expired - Fee Related
- 1999-10-12 EP EP99947537A patent/EP1121099B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6861072B1 (en) | 2005-03-01 |
DE69916640T2 (de) | 2005-03-31 |
FR2784583A1 (fr) | 2000-04-21 |
ES2219062T3 (es) | 2004-11-16 |
WO2000023045A1 (fr) | 2000-04-27 |
CA2347105A1 (en) | 2000-04-27 |
EP1121099B1 (de) | 2004-04-21 |
EP1121099A1 (de) | 2001-08-08 |
PT1121099E (pt) | 2004-08-31 |
CA2347105C (en) | 2009-09-29 |
JP2002527464A (ja) | 2002-08-27 |
AU6094799A (en) | 2000-05-08 |
DK1121099T3 (da) | 2004-08-09 |
FR2784583B1 (fr) | 2002-01-25 |
ATE264666T1 (de) | 2004-05-15 |
AU774723B2 (en) | 2004-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69916640D1 (de) | Im magen verweilendes arzneimittel mit verzögerter wirkstoffabgabe | |
DE69918310D1 (de) | Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff | |
HUP9904174A2 (hu) | Bőrön át történő adagoláshoz szánt gyógyszerkészítmények | |
AU5680100A (en) | Controlled release and taste masking oral pharmaceutical compositions | |
DE69229949D1 (de) | Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe | |
AU2925295A (en) | A novel drug delivery system | |
WO2000061115A3 (en) | Pharmaceutical formulation comprising amoxycillin | |
IT1178430B (it) | Idrogeli polimerici separati in microfase per il rilascio controllato di materiali bioattivi, quali medicinali, antibiotici, contraccettivi e simili | |
AU6517496A (en) | Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole | |
AU6909800A (en) | Metering and packaging of controlled release medication | |
DE69428862D1 (de) | Linsenförmig pharmazeutische Tablette mit verzögerter Freigabe | |
DE60237372D1 (de) | Magenretentionssystem mit kontrollierter arzneimittelfreisetzung | |
WO1998009597A3 (en) | Cushioning beads and tablet comprising the same capable of forming a suspension | |
WO2004000389A3 (en) | Rapidly dissolving micro-perforator for drug delivery and other applications | |
NO995313L (no) | Mikroartikler nyttige som ultrasoniske kontrastmidler og til levering av legemidler i blodbanen | |
NO991921L (no) | Vannoppl°selig film eller vannoppl°selig sjikt som viser °yeblikkelig fuktbarhet for oral tilf°rsel | |
PT1227802E (pt) | Prepacao de pelicula para libertacao bifasica de substancias farmacologicamente activas ou outras | |
NO891680L (no) | Osmotisk kontinuerlig avgivende oralt avgivelsessystem inneholdende et farmasoeytisk akseptabelt aktivt middel som har forbedrede kjernemembran-adhesjonsegenskaper. | |
ATE232100T1 (de) | Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen | |
AU3438897A (en) | Stable drug form for oral administration and process for the preparation thereof | |
DE60225481D1 (de) | Pharmazeutische Formulierungen mit kontrollierter Wirkstoff-Freigabe enthaltend Milchsäure-Polymer und Hydroxynaphthalin-Carbonsäure, sowie deren Herstellung | |
WO2001013899A3 (de) | Wirkstoffhaltiges therapeutisches system mit mindestens zwei polymerhaltigen schichten | |
CO5011082A1 (es) | Formulacion medicamentosa con liberacion controlada de sus- tancia activa | |
ATE306910T1 (de) | Tablette mit verlängerter wirkstoffabgabe im magen | |
WO2002034240A3 (en) | Delayed and sustained release formulations and method of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: SANOFI-AVENTIS, PARIS, FR |
|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1121099 Country of ref document: EP Representative=s name: TER MEER STEINMEISTER & PARTNER GBR PATENTANWA, DE |